Kratom is a plant, Mitragyna speciosa, whose leaves contain psychoactive alkaloids. Products are sold as powders, capsules, extracts and other preparations. Their composition can vary substantially. Kratom can cause dependence and other health problems, and a “natural” label does not establish safety or treatment effectiveness.
What is known about its effects?
Mitragynine and related alkaloids interact with opioid receptors and other biological targets. People report using kratom for pain, mood, energy or opioid withdrawal, but those reported reasons are not proof of clinical benefit. The FDA has not approved kratom or its alkaloids to treat any medical condition.
Botanical kratom and products with added or enhanced 7-hydroxymitragynine, often called 7-OH, should not be treated as interchangeable. The FDA has issued specific warnings about concentrated 7-OH products. A general statement that all kratom is weaker or safer than conventional opioids does not account for product variability or individual risk.
Dependence and problematic use
Repeated exposure can lead to physical dependence, meaning symptoms may occur when use is reduced or stopped. A use disorder involves impaired control and continued use despite significant harm. These concepts overlap but are not identical, and there is no fixed sequence or universal time to addiction.
- Taking more or using more frequently than intended.
- Difficulty cutting down despite wanting to change.
- Spending substantial time obtaining or using products.
- Continuing despite health problems or effects on responsibilities and relationships.
- Withdrawal symptoms when use is reduced.
These are reasons for assessment, not a self-diagnostic checklist. Tell the clinician which products you use, how often, approximately how much and what other medicines or substances are involved. A photograph or packaging may help identify the product.
Health risks and urgent symptoms
Reported adverse effects include nausea, constipation, dizziness and drowsiness. Serious concerns include seizures, liver injury and substance use disorder. Reports involving several substances can be difficult to attribute to kratom alone, but that uncertainty does not make combinations safe. Contamination or inaccurate labeling adds further risk.
Call emergency services for slow or abnormal breathing, a seizure, collapse or difficulty waking someone. Seek urgent medical assessment for jaundice, severe abdominal symptoms, confusion or a suspected overdose. Tell responders about kratom and any other substances taken.
Avoid combining kratom with alcohol, opioids, benzodiazepines or other sedatives. Do not drive when impaired. Do not rely on a seller’s recommended quantity as a medically established safe dose.
Withdrawal and treatment
Withdrawal may involve anxiety, irritability, sleep problems, muscle aches, gastrointestinal symptoms and cravings. Severity and duration vary. A clinician can assess symptoms, product exposure, other substance dependence and co-occurring conditions and agree an appropriate plan. There is no single proven self-directed taper suitable for every product and person.
If you are using kratom to manage pain, anxiety or opioid withdrawal, discuss evidence-based alternatives with a qualified professional. For opioid use disorder, medicines such as methadone or buprenorphine can be part of established care. Do not replace prescribed treatment with kratom without advice.
Support can include medical follow-up, psychological care and practical help. More intensive care may be needed for serious complications or additional substance withdrawal. Treatment should also address the reason someone began using kratom.


